Cardio Diagnostics Holdings Inc

CDIOW



詳細チャートを表示

0.026USD

+0.004+17.73%

終値（ET）15分遅れの株価

0.00時価総額

--直近12ヶ月PER



Cardio Diagnostics Holdings Inc

0.026

+0.004+17.73%

概要企業名金融分析

概要

企業名

金融

分析

Intraday

30m

本日

+17.73%

5日間

-6.16%

1ヶ月

+34.20%

6ヶ月

+59.88%

年初来

0.00%

1年間

-68.76%

詳細チャートを表示

TradingKey 株式スコア

データが不十分なため、株式スコアは利用できません。

Cardio Diagnostics Holdings Inc ニュース

最新情報をお待ちください...

財務指標

EPS

会社から関連データがまだ開示されていません。

総売上高

会社から関連データがまだ開示されていません。

Cardio Diagnostics Holdings Incの企業情報

Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.

企業コードCDIOW

企業名Cardio Diagnostics Holdings Inc

最高経営責任者「CEO」Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.

ウェブサイト